Page last updated: 2024-12-08

isomhpg

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID170451
CHEMBL ID4099482
CHEBI ID125412
SCHEMBL ID22785887
MeSH IDM0075781

Synonyms (16)

Synonym
CHEBI:125412
isomhpg
1-(3-hydroxy-4-methoxyphenyl)ethane-1,2-diol
40979-91-7
isomethoxyhydroxyphenylglycol
isohydroxymethoxyphenylglycol
1,2-ethanediol, 1-(3-hydroxy-4-methoxyphenyl)-
4-methoxy-3-hydroxyphenylethylene glycol
BRD-A52530852-001-01-7
1-(3-hydroxy-4-methoxyphenyl)-1,2-ethanediol
Q27216029
3-hydroxy-4-methoxyphenylethylene glycol
CHEMBL4099482
DTXSID20961361
SCHEMBL22785887
EN300-1853519
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
methoxybenzenesAny aromatic ether that consists of a benzene skeleton substituted with one or more methoxy groups.
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1432864Anti-inflammatory activity in human U937-derived macrophage-like cells assessed as inhibition of LPS-induced IL-6 secretion at 500 uM preincubated for 2 hrs followed by LPS addition measured after 24 hrs by ELISA relative to control2017Bioorganic & medicinal chemistry, 04-01, Volume: 25, Issue:7
Synthesis and anti-inflammatory activity of isoquebecol.
AID1432861Anti-inflammatory activity in human U937-derived macrophage-like cells assessed as inhibition of LPS-induced IL-6 secretion at 125 uM preincubated for 2 hrs followed by LPS addition measured after 24 hrs by ELISA relative to control2017Bioorganic & medicinal chemistry, 04-01, Volume: 25, Issue:7
Synthesis and anti-inflammatory activity of isoquebecol.
AID1432862Anti-inflammatory activity in human U937-derived macrophage-like cells assessed as inhibition of LPS-induced IL-6 secretion at 62.5 uM preincubated for 2 hrs followed by LPS addition measured after 24 hrs by ELISA relative to control2017Bioorganic & medicinal chemistry, 04-01, Volume: 25, Issue:7
Synthesis and anti-inflammatory activity of isoquebecol.
AID1432860Anti-inflammatory activity in human U937-derived macrophage-like cells assessed as inhibition of LPS-induced IL-6 secretion at 250 uM preincubated for 2 hrs followed by LPS addition measured after 24 hrs by ELISA relative to control2017Bioorganic & medicinal chemistry, 04-01, Volume: 25, Issue:7
Synthesis and anti-inflammatory activity of isoquebecol.
AID1432863Anti-inflammatory activity in human U937-derived macrophage-like cells assessed as inhibition of LPS-induced IL-6 secretion at 31.25 uM preincubated for 2 hrs followed by LPS addition measured after 24 hrs by ELISA relative to control2017Bioorganic & medicinal chemistry, 04-01, Volume: 25, Issue:7
Synthesis and anti-inflammatory activity of isoquebecol.
AID1432859Cytotoxicity against human U937-derived macrophage-like cells assessed as reduction in cell viability after 24 hrs by MTT assay2017Bioorganic & medicinal chemistry, 04-01, Volume: 25, Issue:7
Synthesis and anti-inflammatory activity of isoquebecol.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (87.50)18.7374
1990's1 (6.25)18.2507
2000's0 (0.00)29.6817
2010's1 (6.25)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.17 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.11 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (12.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (6.25%)4.05%
Observational0 (0.00%)0.25%
Other13 (81.25%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]